NEW YORK (GenomeWeb News) – RainDance Technologies said today that it has closed a $20 million Series E financing round and that Myriad Genetics has joined as a new strategic equity investor.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.